Acute Kidney Injury and Double Negative T Cells
Acute Kidney Injury and Double Negative T Cells
批准号:
9236186
负责人:
Abdel Rahim Hamad
金额:
$36.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-03-01 至 2020-02-29
关键词:
Activities of Daily LivingAcute Renal Failure with Renal Papillary NecrosisAdoptive TransferAllograftingAntigen-Presenting CellsAutomobile DrivingBiological AssayCD28 geneCD3 AntigensCD8-Positive T-LymphocytesCD8B1 geneCaringCell CompartmentationCellsCessation of lifeCytokine SignalingDataEpithelial CellsEquilibriumEtiologyExperimental Animal ModelFrequenciesGenesGenetic TranscriptionGoalsHealth Care CostsHomeostasisHourHumanImmuneImmunologyIn VitroInflammationInjuryIschemiaKidneyKidney TransplantationLeadLightMedicalMorbidity - disease rateMusNatural regenerationPathogenesisPathogenicityPathway interactionsPhenotypePlayPopulationPropertyProtocols documentationRecoveryReperfusion InjuryReperfusion TherapyRoleSignal TransductionSuggestionT cell responseT-Cell ProliferationT-LymphocyteT-Lymphocyte SubsetsTNFSF5 geneTestingTissuesTransplantationTubular formationWorkbasecell typeclinically relevantcytokineexperimental studyimmunoreactivityimprovedin vivoinsightinterestloss of functionmortalitynovelnovel therapeutic interventionnovel therapeuticspreventprogramsrenal ischemiarepairedresponsetrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Acute kidney injury (AKI) is associated with a high mortality in native kidneys, decreased
allograft survival in transplants, and very high health care costs. Among the most common
etiologies of AKI in both native and transplanted kidneys is ischemia-reperfusion injury (IRI).
Despite advances in medical care, the mortality and morbidity associated with AKI after IRI
remain high, with no specific therapy. A major unknown is the role of different T cell types in
either causing/preventing tissue damage or improving/worsening repair. Detailed understanding
of the roles of different T cell types holds great promise in both elucidating mechanisms
underlying IRI and also in devising new strategies to ameliorate AKI. One such strategy is to
shift the T cell balance in favor of protective T cell types and away from pathogenic ones.
Therefore, it is important to study different T cell types residing and trafficking to the
kidney and investigate their roles in the steady state and IR conditions. Our team has had
a long-standing interest in studying immune cells in AKI using experimental animal models with
translational potential. We recently discovered a unique population of CD4-CD8- double
negative (DN) CD3+TCRab+ T cells that occupies a large niche of the ab T cell compartment in
the normal mouse kidney and undergoes marked changes during AKI. However, their functions
in the normal kidney and AKI pathogenesis remain relatively unknown. Based on strong
preliminary data on DN cells, our overarching hypothesis is that kidney DN T cells play a
major and unique role in regulating renal immune cell homeostasis in the steady state
and after AKI. Our specific Aims are: 1) Investigate mechanisms and significance of steady
state proliferation of kidney DN T cells. 2) Investigate immunoreactivity of DN T cells to IRI
induced AKI. 3) Test the ability of DN T cells to prevent AKI and/or accelerate repair using gain
and loss-of-function strategies. Establishing a functional role for this previously unappreciated
cell type in the kidney will substantially advance our understanding of the kidney immunology
and could lead to paradigm shifting scientific concepts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Acute Kidney Injury and Double Negative T Cells
-
批准号:10360589
-
项目类别:
-
资助金额:$49.68万
-
财政年份:2015
-
负责人:Abdel Rahim Hamad
-
依托单位:
Acute Kidney Injury and Double Negative T Cells
-
批准号:10578792
-
项目类别:
-
资助金额:$48.68万
-
财政年份:2015
-
负责人:Abdel Rahim Hamad
-
依托单位:
Acute Kidney Injury and Double Negative T Cells
-
批准号:8843185
-
项目类别:
-
资助金额:$37.25万
-
财政年份:2015
-
负责人:Abdel Rahim Hamad
-
依托单位:
Mechanisms of Fas Ligand Control of Insulitis in Autoimmune Diabetes
-
批准号:8811093
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2013
-
负责人:Abdel Rahim Hamad
-
依托单位:
Mechanisms of Fas Ligand Control of Insulitis in Autoimmune Diabetes
-
批准号:8627108
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2013
-
负责人:Abdel Rahim Hamad
-
依托单位:
Mechanisms of Fas Ligand Control of Insulitis in Autoimmune Diabetes
-
批准号:8504356
-
项目类别:
-
资助金额:$34.5万
-
财政年份:2013
-
负责人:Abdel Rahim Hamad
-
依托单位:
Mechanisms of Fas Ligand Control of Insulitis Initiation in Autoimmune Diabetes
-
批准号:8440387
-
项目类别:
-
资助金额:$41.06万
-
财政年份:2012
-
负责人:Abdel Rahim Hamad
-
依托单位:
Acute Kidney Injury and Double Negative T Cells
-
批准号:8416321
-
项目类别:
-
资助金额:$20.25万
-
财政年份:2012
-
负责人:Abdel Rahim Hamad
-
依托单位:
Acute Kidney Injury and Double Negative T Cells
-
批准号:8301855
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2012
-
负责人:Abdel Rahim Hamad
-
依托单位:
Fas pathway in organ-specific tolerance and autoimmunity
-
批准号:8124074
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2010
-
负责人:Abdel Rahim Hamad
-
依托单位:
B220+ DN alphabeta T cell as a novel immunoregulatory T*
-
批准号:6947732
-
项目类别:
-
资助金额:$24.53万
-
财政年份:2004
-
负责人:Abdel Rahim Hamad
-
依托单位:
B220+DN Tcells in Mucosal Tolerance and Inflammation
-
批准号:6709782
-
项目类别:
-
资助金额:$16.35万
-
财政年份:2004
-
负责人:Abdel Rahim Hamad
-
依托单位:
B220+DN Tcells in Mucosal Tolerance and Inflammation
-
批准号:6846275
-
项目类别:
-
资助金额:$16.35万
-
财政年份:2004
-
负责人:Abdel Rahim Hamad
-
依托单位:
B220+ DN alphabeta T cell as a novel immunoregulatory T*
-
批准号:6781658
-
项目类别:
-
资助金额:$23.76万
-
财政年份:2004
-
负责人:Abdel Rahim Hamad
-
依托单位: